InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,267.84
(
-0.74%
)
US TECH 100
18,130.00
(
-0.54%
)
Dow Jones
39,065.26
(
-1.53%
)
Brent Oil
81.27
(
-0.32%
)
Bitcoin
67,579.08
(
-2.21%
)
Post# of 693643
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

CherryTree1

Send PM Follow Ignore
Followers 44
Posts 4439
Boards Moderated 0
Alias Born 03/20/2015

CherryTree1

Re: Lorie3168 post# 245251

Monday, 09/23/2019 11:02:09 AM

Monday, September 23, 2019 11:02:09 AM

Post# of 693643
Keytruda is not a personalized immuno-therapy treatment like DCVAX where the treatment is unique for each patient. It is a checkpoint inhibitor so it can be called immuno-therapy I suppose, but it is just like chemotherapy where it is the same treatment for everyone so they can more easily mass produce it. This is consistent with the chemotherapy business model. Like many checkpoint inhibitors it can have significant and life threatening side effects as well.

Men who are occupied in the restoration of health to other men, by the joint exertion of skill and humanity, are above all the great of the earth. They even partake of divinity, since to preserve and renew is almost as noble as to create.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News
InvestorsHub NewsWire

Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM

Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM

"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM

North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM

Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM

Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM

Start posting your company's news
Only $200 per official company press release!